Choroidal Thickness Association With Primary Angle Closure
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03050073 |
Recruitment Status :
Completed
First Posted : February 10, 2017
Last Update Posted : August 10, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Choroidal Thickness |
Study Type : | Observational [Patient Registry] |
Actual Enrollment : | 42 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 30 Days |
Official Title: | Choroidal Thickness Association With Primary Angle Closure |
Actual Study Start Date : | April 18, 2016 |
Actual Primary Completion Date : | June 30, 2016 |
Actual Study Completion Date : | December 31, 2016 |
- change of choroidal thickness measurement by Imaging of the fundus oculi (OCT swept source) [ Time Frame: Day 1 Day 30 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Age >18 years
- Primary angle closure confirmed by gonioscopy
- interpretable images for choroidal thickness measure
- interpretable images by Ultra Bio Microscopy (UBM)
Exclusion Criteria:
- Acute crisis for angle closure
- Rethinopathy (diabetic or hypertensive)
- Histories of intra-eye surgery
- Great myopia
- Hypermetropia
- retinal pathology

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03050073
France | |
Groupe Hospitalier Paris Saint Joseph | |
Paris, Ile-de-France, France, 75014 |
Study Director: | Hélène BEAUSSIER, Pharm-D | CRC |
Responsible Party: | Groupe Hospitalier Paris Saint Joseph |
ClinicalTrials.gov Identifier: | NCT03050073 |
Other Study ID Numbers: |
IRIS |
First Posted: | February 10, 2017 Key Record Dates |
Last Update Posted: | August 10, 2018 |
Last Verified: | August 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |